CVS Health Corp (N:CVS)

Business Focus: Drug Retailers

Recent Price for CVS
USD 71.900 +1.410 (+2.000%)
NYSE Delayed 15 minutes
Feb 16 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
72.210 84.000 11.12 6,469,876 72,944.86
1-Day Low 52-Week Low Yield Avg. Volume  
70.320 66.450 2.8% 9,092,833  
Competitors with Recent Insider Filings
McKesson (N:MCK)
AmerisourceBergen (N:ABC)
Cardinal Health (N:CAH)
Latest 10 SEC filings (by transaction date) for CVS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 9/18 Nov 8/17 Roberts Jonathan C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -222 $68.99
Nov 9/17 Nov 8/17 White Tony L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,521 $68.99
Nov 9/17 Nov 8/17 Millon Jean Pierre Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,521 $68.99
Nov 9/17 Nov 8/17 Dorman David W Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,131 $68.99
Nov 9/17 Nov 8/17 Deparle Nancy Ann Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,521 $68.99
Nov 9/17 Nov 8/17 Bracken Richard M Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,630 $68.99
Nov 9/17 Nov 8/17 Decoudreaux Alecia A Direct Ownership Share Credits A - Grant, award or other under Rule 16b-3(d) 2,029 $68.99
Nov 9/17 Nov 8/17 Schapiro Mary L Direct Ownership Share Credits A - Grant, award or other under Rule 16b-3(d) 2,029 $68.99
Nov 9/17 Nov 8/17 Finucane Anne A. Direct Ownership Share Credits A - Grant, award or other under Rule 16b-3(d) 1,522 $68.99
Nov 9/17 Nov 8/17 Weldon William C Direct Ownership Share Credits A - Grant, award or other under Rule 16b-3(d) 2,029 $68.99
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for CVS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 9/18 Nov 8/17 Roberts Jonathan C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -222 $68.99
Nov 9/17 Nov 8/17 White Tony L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,521 $68.99
Nov 9/17 Nov 8/17 Millon Jean Pierre Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,521 $68.99
Nov 9/17 Nov 8/17 Dorman David W Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,131 $68.99
Nov 9/17 Nov 8/17 Deparle Nancy Ann Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,521 $68.99
Nov 9/17 Nov 8/17 Bracken Richard M Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,630 $68.99
Nov 9/17 Nov 8/17 Decoudreaux Alecia A Direct Ownership Share Credits A - Grant, award or other under Rule 16b-3(d) 2,029 $68.99
Nov 9/17 Nov 8/17 Schapiro Mary L Direct Ownership Share Credits A - Grant, award or other under Rule 16b-3(d) 2,029 $68.99
Nov 9/17 Nov 8/17 Finucane Anne A. Direct Ownership Share Credits A - Grant, award or other under Rule 16b-3(d) 1,522 $68.99
Nov 9/17 Nov 8/17 Weldon William C Direct Ownership Share Credits A - Grant, award or other under Rule 16b-3(d) 2,029 $68.99
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $CVS

StockTwits